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Abstract: Background: Complete follow up is an essential component of observational cohorts irrespective of the type of 
disease. 
Objectives: To describe five years follow up of mother and child pairs on a PMTCT program, highlighting loss to follow 
up (LTFU) and mortality (attrition). 
Study Design: A cohort of pregnant women was enrolled from the national PMTCT program at 36 weeks gestational age 
attending three peri urban clinics around Harare offering maternal and child health services. Mother-infant pairs were 
followed up from birth and twice yearly for five years. 
Results: A total of 479 HIV infected and 571 HIV negative pregnant women were enrolled, 445(92.9%) and 495(86.6%) 
were followed up whereas 14(3.0%) and 3(0.5%) died in the 1
st year respectively; RR (95%CI) 5.3(1.5-18.7). At five 
years 227(56.7%) HIV infected and 239(41.0%) HIV negative mothers turned up, whereas mortality rates were 34 and 7 
per 100 person years respectively. Birth information was recorded for 401(83.7%) HIV exposed and 441(77.2%) 
unexposed infants, 247(51.6%) and 232(40.6) turned up in the first year whilst mortality was 58(12.9%) and 22(4.4%) 
respectively, RR (95%CI) 3.2(2.0-5.4). At five years 210(57.5%) HIV exposed and 239(44.3%) unexposed infants were 
seen, whilst mortality rates were 53 per 1000 and 15 per 1 000 person years respectively. Mortality rate for HIV infected 
children was 112 compared to 21 per 1 000 person years for the exposed but uninfected. 
Conclusion: HIV infected mothers and their children succumbed to mortality whereas the HIV negatives were LTFU. 
Mortality rates and LTFU are high within PMTCT program. 
Keywords: HIV, Follow up, Mortality, PMTCT. 
INTRODUCTION 
In 2000, WHO responding to the HIV pandemic 
recommended that interventions to prevent mother to child 
transmission (PMTCT) of HIV interventions with a four 
pronged approach based on antenatal voluntary counselling 
and testing(VCT) of all pregnant women and that 
antiretroviral (ARV) treatment should be integrated within 
all maternal and child health (MCH) programs. PMTCT 
interventions were accepted in Zimbabwe as a national 
program in 2001, whilst it is estimated that up to 12% of 
infants in Zimbabwe are infected with HIV [1-5]. 
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  The success of PMTCT is based on complete follow up 
of mothers and infants to ensure maximum compliance and 
retention that allows correct timing of interventions. The 
major challenge in the successful implementation of the 
PMTCT protocol is loss to follow up (LTFU) and mortality 
(attrition). Attrition results in a weak link between PMTCT 
initiatives of identifying and monitoring HIV exposed and 
unexposed infants in the under 5 child health clinics [6-12]. 
PMTCT outcomes reported are based mainly on those 
mother child pairs who retained within programs, leading to 
limited information of those that died and the ones that are 
LTFU. 
  Literature shows that high attrition within PMTCT 
programs could be more of LTFU than of mortality. 
Cumulative losses in sub-Saharan African PMTCT programs 
are estimated to range from 20-28% during antenatal care, up 
to 70% at four months postpartum and close to 81% at six 52    The Open AIDS Journal, 2011, Volume 5  Kurewa et al. 
months after birth [7,9,13-18]. Complete follow up is an 
essential component of all observational cohorts irrespective 
of the type of disease [19]. 
  Our study, Better Health for The African Mother and 
Child (BHAMC) recruited pregnant women from the 
Zimbabwe national PMTCT program before CD4 
monitoring and long term ARV therapy was readily available 
and affordable in the country. In this paper we describe 5 
years follow up of mothers and children within a PMTCT 
intervention with a special focus on attrition. The aim is to 
highlight the reality of following mother and child pairs 
beyond the stipulated PMTCT 24 months. Identification of 
the time points when high attrition occurs will guide 
planning and targeting of interventions to maximize 
compliance which is needed to improve mother’s health and 
child. 
MATERIALS AND METHODS 
  Design of the study: A cohort of mother and child pairs 
was recruited from the national PMTCT program and 
followed up for five years. 
 Study  sites: Three peri urban clinics around Harare the 
capital city of Zimbabwe, namely; Epworth; St Marys and 
Seke North. These are primary health care settings offering 
maternal and child health services. 
 Study  population:  Pregnant women booked at the 
respective Antenatal Clinics (ANC), who have gone through 
the national PMTCT (VCT) were followed up together with 
their index children from birth up to 5 years. 
  Inclusion criteria: Pregnant women from 36 weeks of 
gestation coming through the national PMTCT program. 
Pregnant women with known complications and who not had 
to deliver at a primary health care setting were excluded. 
 Sample  size:  The intention was to recruit 300 HIV 
positive and 600 HIV negative pregnant women allowing for 
10% LFU. 'EPISTAT' program was used to calculate the 
sample size. 
  Baseline assessments of mothers: A questionnaire 
sourcing socio demographic, life styles and living 
conditions, obstetric and reproductive history, contraception 
and knowledge of STI/HIV signs and symptoms was 
administered to the women at enrolment. In addition to 
routine antenatal care women were screened for other 
sexually transmitted infections and reproductive tract 
infections (RTI)s. Those found infected were treated and 
encouraged to inform their sexual partners to come for 
treatment which was given for free. 
  A locator form was used to document the physical and 
postal address of the mother or care giver and next of kin 
details were obtained for those who consented to home 
visits, where available contact telephone numbers were 
obtained for follow up purposes. Trained counselors residing 
in the same community were responsible for the follow up of 
those participants who missed their scheduled visits. All 
transport costs were reimbursed, whilst all clinical care 
expenses related to any clinical event were supported by the 
project. 
 Intervention: At birth HIV infected mothers received a 
single 200-mg Nevirapine dose at the onset of labor, and 
their infants received a single 1-2 mg Nevirapine dose within 
72 hours of delivery (sdNVP). Nevirapine was provided by 
the government of Zimbabwe under the national PMTCT 
program. 
  Support groups were introduced during the second year 
of follow up where women met clinician once every week. 
At each study clinic women were encouraged to form one 
group for both HIV infected and negative women. They 
chose a convenient day where they would meet at a specified 
time for up to 2 hours and a coordinator amongst themselves 
to act as a link person between them and the researchers. 
  Health education talks were given to the women 
interacting with the research nurses, counselors, psychologist 
and sociologist to respond to their concerns in a participatory 
manner. Women were also given an opportunity to suggest 
topics which they felt relevant to their day to day lives. They 
were encouraged to bring their spouses and significant 
members like mothers’ in law or any caregiver for the index 
child where the mother had been lost. 
 Note: Enrolment was done during the time when 
prolonged ARVs were not readily available in the country 
except for the sdNVP, whereas CD4 counts were not 
routinely done at government institutions due to prohibitive 
costs. However over the follow up period when they became 
available and affordable the project facilitated referral for the 
HIV infected and exposed children to access both CD4 
counts and ARVs when indicated from the government 
opportunistic clinics (OI). 
 Follow  up: This was conducted within the same study 
clinics where maternal and child health services are 
provided. A separate room was provided for the study 
procedures throughout the follow up period. Mothers were 
followed up according to their expected date of term (EDT) 
to ascertain site and mode of delivery and for the HIV 
infected to ensure provision of NVP. A birth form was used 
to document birth information; onset of labour, time of 
rupture of membranes, duration of labor, collection of 
venous blood and for the HIV infected women, time of 
ingesting Nevirapine tablet. 
  All mothers and their infants were followed up for 6 
weeks, four and nine months and every six months thereafter 
for five years. Mother and child health status was assessed 
and documented in the appropriate form according to the age 
after birth. Infant feeding practices were assessed and 
documented at each visit. HIV infected mothers and their 
exposed infants were given prophylactic cotrimoxazole. For 
the exposed infants cotrimoxazole would be stopped if they 
tested negative for HIV. 
  HIV infected mothers had a general physical and 
gynaecological examination performed together with CD4 
counts that were assessed every six months. Those with a 
low CD4 count (<less than 200 mm/l would be send for a 
chest x- ray, blood chemistry; liver function tests (LFTs), 
Urea and electrolytes (U & Es and full blood count (FBC) 
for easy access and referral to the government opportunistic 
infection (OI) clinics for ARV therapy. 
  Outcome information was when the study participants 
were considered to be alive; they turned up for their 
scheduled visit, they could be contacted over the phone, Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe  The Open AIDS Journal, 2011, Volume 5    53 
could be seen at home or if a spouse or close relative, or care 
giver of the child could confirm that they were alive during 
the period under observation. They were considered 
deceased if a spouse, close relative, landlord or neighbor 
seen at their house or nearby confirmed verbally or medical 
records that confirmed their death. 
  In the case where the visit was unsuccessful, they were 
not proven as deceased or alive and follow up visits would 
have been repeated for unspecified times and all channels of 
contact exhausted. They would then be considered as LFU. 
  Children’s follow up: Follow up of the commenced from 
birth for both HIV exposed and unexposed neonates was 
carried out. Birth information was recorded in an infant birth 
form by the midwife regarding status of the neonate at birth; 
alive or still born, Apgar score, physical examination 
including anthropometrical measurements and collection of a 
cord blood sample for the HIV exposed infants. 
  Thereafter venous blood was collected at each follow up 
visit; 6 weeks, 4 and 9 months for HIV- DNA PCR test using 
cell pellets by prototype Roche Amplicor version 1.5 
qualitative PCR assay (Roche Diagnostic Systems). At six 
weeks cotrimoxazole suspension was given to all HIV 
exposed infants until they were screened and found negative. 
At each visit a health status was documented in the 
appropriate form according to age at visit after a complete 
physical examination of the infant together with 
anthropometric measurements and feeding practices. 
  A Bailey Infant Neurological development test (BINS) 
was performed from 3 to 24 months. Thereafter the children 
continued to have a general health status assessment every 
six months performed by the study paediatrician. HIV 
exposed infants were screened for HIV one month after 
cessation of breastfeeding and from 15 months onwards. 
  HIV infected infants had a full blood count test (FBC), 
blood chemistry tests and CD4 counts every six months. 
Where the infants indicated were referred to OI clinics to be 
commenced on ARVs. 
  Infants were classified at birth according to maternal HIV 
status that was determined at approximately 36 weeks of 
gestation and this status was maintained for the analysis of 
this paper. At each scheduled visit information was sourced 
from the mother or care giver about the health status of the 
infant. Those who did not turn up for the scheduled visit 
were followed up to ascertain reason for defaulting. If found 
they would be rescheduled for the next visit. 
  An infant was considered as LTFU if he was not brought 
in for the stipulated visit and not declared as deceased by 
either the parents or caregiver. The infants were considered 
dead through evidence from verbal autopsy for the baby 
given by either the mother or care giver or when available 
clinical records were analyzed to ascertain cause of death. 
  Attrition, (defined as the total sum of those who were 
LTFU and those that died) was assessed at each scheduled 
visit over the five years. 
 Ethical  Considerations: Both the Medical Research 
Council of Zimbabwe and the Ethical Review Committee in 
Norway approved the study. Mothers who agreed to   
 
participate gave an informed written consent that covered 
themselves and their index babies to be followed up from 
birth. 
 Statistical  Analysis:  Data were entered and analyzed 
using SPSS and STATA Version 9 from StataCorp Texas 
USA. All mothers enrolled in pregnancy were assessed 
whilst all live born infants were available for analysis. In the 
case of multiple births only the first born was included to 
avoid mixing up of the children. Baseline characteristics 
were compared using Pearson X
2 test for categorical 
variables and independent sample student’s t test for 
continuous variables. 
  Follow up of mothers and infants reflecting on those 
seen, LFU and deceased at each scheduled visit from birth to 
5 years is demonstrated by a flow diagram (Figs. 1, 2). 
  Scheduled visits were combined from birth up to one 
year to summarize those ever seen and those who were 
LTFU and the ones that died as outcome information. Risk 
ratios with their 95% CI of dying or being lost to follow up 
were estimated over the 1
st year and at five years using 
maternal HIV status at enrolment. 
  Follow up time was measured in months from enrolment 
up to 60 months ending at the earliest month of death and 
ending at the last follow up visit, date of last contact. The 
statistical significance threshold was 5%, whilst all reported 
p values were 2 sided. 
RESULTS 
  A total of 1050 pregnant women were enrolled from 36 
weeks of gestation being 479 HIV infected and 571 HIV 
negatives. Their mean ages were 26.0 yrs (s.d 4.9) for the 
HIV infected and 23.5 yrs(s.d 4.8) for the HIV negatives and 
reported mean pregnancy (s.d) 1.9(0.41) and 1.6(0.5) 
respectively p<0.001. Birth information revealed that 7 
infants were stillborn, 5 from the HIV infected and 2 from 
HIV negative mothers; whereas 4(0.8%) HIV infected 
women and 11(1.9%) HIV negative women refused 
continued participation after birth p<0.001. 
  Birth information was obtained from 851(81.0%) 
mothers, 406 HIV positive and 445 HIV negatives that gave 
birth within the study sites whilst 11 mothers delivered at 
referral hospitals due to recorded complications. A total of 
318(66.4%) mother infant pairs took NVP. Three hundred 
and ninety one (81.6%) HIV exposed children were screened 
for HIV over the five years and 97 of them were infected 
with HIV through MTCT giving an overall transmission rate 
of 21.8% CI (17.8-25.8). This is fully described in another 
paper. 
  Mothers’ follow up:  Over the first year more mothers 
were LFU among the HIV negatives 76 (13.4%) compared to 
the HIV infected 34 (7.3%) p= 0.012. In the same period 
more mothers were lost due to mortality among the HIV 
infected compared to the HIV negatives. At five years LFU 
was not different among the HIV infected and negative 
mothers, odds ratio (OR) (95%CI) 1.6(0.9-2.7). Mortality for 
mothers continued to rise over the five years regardless of 
their HIV status. Risk ratios for LFU and mortality for HIV 
infected and negative mothers are shown in Table 1. 54    The Open AIDS Journal, 2011, Volume 5  Kurewa et al. 
 Figs.  (1, 2) illustrate flow of mothers and children during 
the five years of follow up based on the maternal HIV status 
at enrolment. A total of 253(52.8%) HIV positive mothers 
consistently showed up at each of the scheduled follow up 
visits compared to 203(35.5) HIV negatives p<0.001. 
  Throughout the follow up period, 369(77.0%) HIV 
infected and 480(84.1%) HIV negative mothers were seen 
both in the first year and over the five years respectively. A 
total of 187(46.8%) HIV infected and 166(30.1) HIV 
negative mothers were coming consistently at each of the 
scheduled 11-12 visits over the five years p<0.001. 
 
Fig. (1). Mothers follow Up over 5 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
1050 pregnant mothers at 
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65 Deaths
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  A total of 227(56.7%) HIV infected mothers responded 
to the 60 months questionnaire compared to 233(43.0) HIV 
negatives p= 0.013. Over the five years, 305(63.8%) HIV 
infected mother and child pairs turned up at different time 
points compared to 459(80.4%) HIV negatives p>0.05 whilst 
36(7.5%) HIV infected mother and child pairs died 
compared to 4(0.7%) among the HIV negatives p<0.001. 
  Follow up of children:  A total of 247 (58.7%) HIV 
exposed and 232 (43.5%) HIV unexposed children showed 
 
Fig. (2). Infants follow up over 5 years. 
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up for the one year visit p<0.001 whilst 58(12.1%) compared 
to 22(3.9%) died respectively p<0.001. 
  There were 223(52.9%) HIV exposed compared to 
194(35.3%) unexposed children turning up consistently for 
each of the scheduled (4) visits over the first year of follow 
up p= 0.002 (Fig. 2). 
  Throughout the five years of follow up, 391(82.5%) HIV 
exposed children were screened for HIV at various time 
points and 97(24.8%) of them were HIV seropositive. 
Among the HIV infected infants, 23(23.7%) died in the first 
year, whilst 43/74(58.1%) died after their first birthday. 
  Overall 5 years mortality of the HIV infected children 
was 66(68.0%), with mortality rates of 112 compared to 21 
per 1  000 person years among the HIV exposed but not 
infected children. 
  A significant difference was observed in the compliance 
of children by maternal HIV status at 5 years, with 
210(57.5%) HIV exposed children turning up for scheduled 
visits compared to 239(45.1%) those born of HIV negative 
mothers, p<0.001. A total of 137(37.5%) HIV exposed 
infants and 112(21.5%) HIV negative mothers consistently 
turned up for each visit throughout the five years, p<0.001. 
  Cumulative 5 years child mortality was 114(23.8%) 
among HIV exposed children and 41(7.2%) for those not 
exposed, p<0.001; mortality rates were 53 per 1000 and 15 
per 1 000 person years for the HIV exposed and unexposed 
respectively. During the five years of follow up 16(4.4%) 
HIV exposed and 51(9.6%) unexposed children were not 
able to be traced at all p= 0.001. 
DISCUSSION 
  This study highlights a natural flow of mother and child 
pairs followed up from a PMTCT program before routine 
CD4 counts were affordable and there was availability of 
long term ARV therapy in low resource settings. Less than 
10% of both mothers and children were completely LTF 
regardless of HIV status. Outcome information was obtained 
for up to ninety percent of both HIV infected and negative 
mothers and their children whilst actual retention was fifty 
and forty percent respectively over the five years. 
  Mothers who did not have birth information were mostly 
referral cases who developed complications during birth and 
were referred or transferred for higher level of care at the 
central hospitals for further management whereas some had 
decided not to give birth at the study clinics. Others were 
those who later decided not to give birth elsewhere outside 
the study sites. 
  Our retention rate is higher compared with other African 
studies although few of them have continued PMTCT follow 
up for more than 2 years [6]. NVP intake for our cohort was 
higher than the national and other regional reports at that 
time. This could be due to the extra health education and 
close monitoring of participants within research initiatives 
[20] and the 2006 ZDHS. 
  Attrition was mainly due to high mortality among the 
HIV infected mothers and their children, whilst the HIV 
negative mothers and their children were LTFU. Mortality of 
the HIV infected mothers and exposed children was higher 
in the first year but with time the HIV negative mothers and 
children were also dying [21]. 
  Child mortality decreased with age whereas that of the 
mothers increased with time. This explains that the high 
number of orphaned children in Zimbabwe as HIV exposed 
children survive more than their HIV infected parents as 
reflected in the Zimbabwe demographic health survey. 
  Other factors besides HIV infection could be influencing 
this gradual increase in mortality observed even among the 
HIV negatives too. Mortality rates are consistent with what 
other studies in the region have reported from the 
stipulated/recommended PMTCT follow up of two years 
after birth [1,6,13,15,22-25]. 
  Mortality of the HIV infected children was lower 
compared to other reports where it ranged from 50 to 80% 
over two years [6,15, 23, 26, 27]. This could be due to the 
early provision and constant supply of prophylactic 
cotrimoxazole by the study and availability of a paediatrician 
who offered timeous management and referrals for ARV 
therapy. These mortality figures are quite representative as 
we managed to get over ninety percent outcome information 
compared to reports from other studies [26, 28,29]. 
Table 1.  Risk of LFU and Mortality of HIV Positive and Negative Mothers and their Children 
 
 LFU  and   
Mortality 
HIV
POSITIVE  
N=479 
HIV
NEGATIVE  
N= 571 
Risk  
Ratio 
Mothers 
Visit during first year 
 
 
Visit over five years 
 
LFU 
Deceased 
 
LFU 
Deceased 
 
34(7.3%) 
14(3.1%) 
 
25(5.2%) 
79(16.5) 
 
76(13.4%) 
3(0.6%) 
 
54(9.5%) 
19(3.3) 
 
1.96(1.28-2.99) 
5.32(1.52-18.66) 
 
1.63(0.99-2.66) 
5.52(3.29-9.27) 
Children 
Visit during first year 
 
 
Visit over five years 
 
LFU 
Deceased 
 
LFU 
Deceased 
 
31(7.4%) 
58(12.9%) 
 
16(3.3%) 
114(23.8%) 
 
72(13.1%) 
22(4.4%) 
 
51(8.9%) 
41(7.2%) 
 
1.89(1.22-2.95) 
3.22(1.94-5.36) 
 
2.32(1.30-4.14) 
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  Mortality of the HIV infected children reflects the need 
for early provision of ARVs. This is in line with 
observations and concerns that HIV exposed children are 
turning up late for HIV screening, when they are already sick 
being in the AIDS stage [12, 14,30]. This is attributed to the 
weak link and integration of PMTCT interventions with the 
traditional under five child health clinics. This would 
provide an easy access and early identification of HIV 
exposed children and those found infected would be referred 
to OI clinics for further management. 
  The omitted visit at birth meant a missed opportunity for 
NVP intake for the HIV infected mother and exposed infant 
and this compromized the outcome of infections averted and 
generalizability to other studies. Estimation of MTCT rates 
of HIV from birth throughout the breastfeeding period is 
distorted when exposed children are screened for HIV at 
different time points. Other studies have reported that 
inadequate follow up of infants post delivery leads to poor 
quantification of infections averted [31]. 
  Six weeks is an existing cardinal established WHO 
stipulated visit for women’s post natal examination and that 
of their infants. Women who missed the opportunity to have 
a pap smear taken which is important for cervical screening 
of cancer regardless of one’s HIV status. The HIV negative 
mothers not showing up for scheduled visits missed the HIV 
screening test thereby affecting the quantification of HIV 
incidence rate for this cohort. With only thirty percent being 
consistently screened for HIV it becomes difficult to 
generalize the results as they were not the same women who 
were being screened at the same time points. 
  LTFU of children during this period when they are 
supposed to be attending the under 5 child health clinics for 
growth monitoring and immunizations has been reflected in 
the low vaccination coverage reported in the country over the 
same period [20]. 
  More than twenty percent of the outcome information 
obtained for the HIV infected and exposed children was on 
mortality whilst for the HIV negatives it was LTFU. HIV 
infected mothers need to have CD4 counts every six months 
whilst the HIV negatives should appreciate the importance of 
taking an HIV test at least every six months or yearly. 
  Mothers should be given health education on the 
importance of growth monitoring and immunization of 
children emphasizing complete vaccination regardless of 
maternal HIV status. Mortality figures for mothers and 
children should be included in the HIV prevention messages 
in the respective communities. This will assist couples to 
make informed decisions regarding HIV infection and future 
pregnancies. 
  The strength of this study is the valuable information of 
mothers and children documented over five years which is 
useful for planning of maternal and child health 
interventions. The 30% HIV infected children surviving after 
their 5
th birthday require a targeted health care plan 
according to their specific needs besides provision of 
HAART. We conclude that HIV infected mothers and 
exposed children mainly die due to mortality, whilst the HIV 
negatives and their children are LTFU. Attrition over five 
years was similar regardless of maternal HIV status, 
meaning that factors other than HIV status could be 
influencing it. Outcome measures are compromized because 
of the irregular compliance as different mothers and children 
turn up at different time points. Mortality and HIV incidence 
figures should be disseminated to the concerned respective 
communities for them to make informed decisions regarding 
compliance. 
  Emphasis on complete follow up care regardless of HIV 
status should be part of all health care programs. We support 
integration of PMTCT initiatives into HIV health care 
services for a holistic approach to service provision. There is 
need to ascertain factors that influence high attrition within 
follow up studies. 
  This information will aid in informing program 
coordinators and health care policy makers to improve 
tracking methods and directing more effort towards targeting 
those time points where attrition is indicated to be highest. 
  The main limitation is that we did not describe the 
predictors of this attrition and that we lacked a comparison 
group that followed up mother and child pairs from a 
PMTCT program over 5 years. 
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